CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2019	Dec. 31, 2018	[1]
Current assets:
Cash and cash equivalents	$ 141,952	$ 62,417
Short-term marketable securities	107,711	52,491
Related party receivables from collaborative arrangements	67,563	83,286
Prepaid expenses and other current assets	459	849
Total current assets	317,685	199,043
Property and equipment, net	136	160
Operating lease right-of-use asset	1,348	0
Capitalized fees paid to a related party, net	145,987	152,899
Deferred tax assets	177,114	196,054
Other assets	37	37
Total assets	642,307	548,193
Current liabilities:
Accounts payable	1,139	11
Accrued personnel-related expenses	371	470
Accrued interest payable	4,262	4,264
Other accrued liabilities	1,386	955
Operating lease liability, current portion	317	0
Total current liabilities	7,475	5,700
Long-term debt, net of discount and issuance costs	386,675	382,855
Operating lease liability, net of current portion	1,157	0
Other long-term liabilities	298	586
Commitments and contingencies
Stockholders' equity
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding	0	0
Common stock: $0.01 par value, 200,000 shares authorized, 101,272 and 101,098 issued and outstanding as of June 30, 2019 and December 31, 2018, respectively	1,013	1,011
Additional paid-in capital	1,257,799	1,256,267
Accumulated other comprehensive income (loss)	33	(3)
Accumulated deficit	(1,032,162)	(1,103,692)
Total Innoviva stockholders' equity	226,683	153,583
Noncontrolling interest	20,019	5,469
Total stockholders' equity	246,702	159,052
Total liabilities and stockholders' equity	$ 642,307	$ 548,193

[1] Condensed consolidated balance sheet as of December 31, 2018 has been derived from audited consolidated financial statements.